Showing results (11-20 of 78) with videos related to
Sort By:
Pageof 8
Journal of Biopharmaceutical Statistics|October 11, 2023
The impact of misclassification errors on the performance of biomarkers based on next-generation sequencing, a simulation studyDong Wang, Sue-Jane Wang, Samir LababidiJournal of Biopharmaceutical Statistics|July 16, 2019
The i3+3 design for phase I clinical trialsMeizi Liu, Sue-Jane Wang, Yuan JiControlled Clinical Trials|April 12, 2003
Assessing treatment efficacy in noninferiority trialsSue-Jane Wang, H M James HungContemporary Clinical Trials|May 21, 2021
Hi3 + 3: A model-assisted dose-finding design borrowing historical dataYunshan Duan, Sue-Jane Wang, Yuan JiJournal of Biopharmaceutical Statistics|June 23, 2004
Multiple testing of noninferiority hypotheses in active controlled trialsH M James Hung, Sue-Jane WangJournal of Biopharmaceutical Statistics|September 6, 2012
Ethnic sensitive or molecular sensitive beyond all regions being equal in multiregional clinical trialsSue-Jane Wang, H M James HungJournal of Biopharmaceutical Statistics|July 19, 2005
Adaptive covariate adjustment in clinical trialsSue-Jane Wang, H M James HungJournal of Biopharmaceutical Statistics|January 8, 2014
A regulatory perspective on essential considerations in design and analysis of subgroups when correctly classifiedSue-Jane Wang, H M James HungBiometrical Journal. Biometrische Zeitschrift|July 1, 2010
Challenges to multiple testing in clinical trialsH M James Hung, Sue-Jane WangContemporary Clinical Trials|October 1, 2015
An integrated dose-finding tool for phase I trials in oncologyShengjie Yang, Sue-Jane Wang, Yuan JiPageof 8